Kaposi's Sarcoma-associated Herpesvirus (KSHV)/Human Herpesvirus 8 (HHV-8) as a Tumour Virus

Herpes

Volumn 10, Issue 3, 2003, Pages 72-77

  Cathomas, Gieri ^a,b  

^a Cantonal Institute of Pathology   (Switzerland)

^b Cantonal Institute of Pathology   (Switzerland)

Author keywords

Human herpesvirus 8 (KSHV HHV 8); Kaposi's sarcoma (KS); Kaposi's sarcoma associated herpesvirus (kSHV); Multicentric Castleman's disease (MCD); Oncogenesis; Pathogenesis; Primary effusion lymphoma (PEL)

Indexed keywords

CYTOKINE; G PROTEIN COUPLED RECEPTOR; LATENCY ASSOCIATED NUCLEAR ANTIGEN; PROTEIN P53;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ANGIOGENESIS; APOPTOSIS; CELL PROLIFERATION; GENE EXPRESSION; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; LYMPHOPROLIFERATIVE DISEASE; NONHUMAN; ONCOVIRINAE; PARACRINE SIGNALING; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; REVIEW; SEQUENCE HOMOLOGY; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

GENE EXPRESSION REGULATION, VIRAL; GENOME, VIRAL; GIANT LYMPH NODE HYPERPLASIA; HERPESVIRUS 8, HUMAN; HUMANS; LYMPHOMA; SARCOMA, KAPOSI;

HERPESVIRIDAE; HERPESVIRUS 8; HUMAN HERPESVIRUS 8; ONCOVIRINAE;

EID: 0346655309     PISSN: 09697667     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-1869.
2. Antman K, Chang Y. Kaposi's sarcoma. N Engl J Med 2000;342:1027-1038.
3. Cathomas G. Human herpes virus 8: a new virus discloses its face. Virchows Arch 2000;436:195-206.
4. Jenner RG, Boshoff C. The molecular pathology of Kaposi's sarcoma-associated herpesvirus. Biochim Biophys Acta 2002;1602:1-22.
5. Moore PS, Chang Y. Kaposi's sarcoma-associated herpesvirus. In: Fields Virology, 4th edn (Knipe DM, Howley PM, eds). Philadelphia: Lippincott Williams & Wilkins, 2001;pp2803-2834.
6. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995;332:1186-1191.
7. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995;86:1276-1280.
8. Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 1990;335:123-128.
9. Penn I. Kaposi's sarcoma in transplant recipients. Transplantation 1997;64:669-673.
10. Lamovec J, Knuutila S. Kaposi sarcoma. In: World Health Organization Classification of Tumors. Tumors of Soft Tissue and Bone (Fletcher CDM, Unni KK, Mertens F, eds). Lyon: IARC Press, 2002;pp170-172.
11. Cathomas G, McGandy CE, Terracciano LM, Itin PH, De RG, Gudat F. Detection of herpesvirus-like DNA by nested PCR on archival skin biopsy specimens of various forms of Kaposi sarcoma. J Clin Pathol 1996;49:631-633.
12. Cathomas G, Tamm M, McGandy CE, Itin PH, Gudat F, Thiel G et al. Transplantation-associated malignancies: Restriction of human herpes virus 8 (HHV8) to Kaposi's sarcoma. Transplantation 1997;64:175-178.
13. Sturzl M, Blasig C, Schreier A, Neipel F, Hohenadl C, Cornali E et al. Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma. Int J Cancer 1997;72:68-71.
14. Katano H, Sato Y, Kurata T, Mori S, Sata T. High expression of HHV-8-encoded ORF73 protein in spindle-shaped cells of Kaposi's sarcoma. Am J Pathol 1999;155:47-52.
15. Raphael M, Borisch B, Jaffe ES. Lymphomas associated with infection by the human immune deficiency virus (HIV). In: World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of Hematopoietic and Lymphoid Tissues (Jaffe ES, Harris NL, Stein H, Vardiman W, eds). Lyon: IARC Press, 2001.
16. Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Said JW et al. Primary effusion lymphoma: A distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996;88:645-656.
17. Peterson BA, Frizzera G. Multicentric Castleman's disease. Sem Oncol 1993;20:636-647.
18. Parravicini C, Corbellino M, Paulli M, Magrini U, Lazzarino M, Moore PS et al. Expression of a virus-derived cytokine, KSHV vIL-6 in HIV-seronegative Castleman's disease. Am J Pathol 1997;151:1517-1522.
19. Chiou CJ, Poole LJ, Kim PS, Ciufo DM, Cannon JS, ap Rhys CM et al. Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus. J Virol 2002;76:3421-3439.
20. Du MQ, Liu H, Diss TC, Ye H, Hamoudi RA, Dupin N et al. Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood 2001;97:2130-2136.
21. Dupin N, Diss TL, Kellam P, Tulliez M, Du MQ, Sicard D et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 2000;95:1406-1412.
22. Evans AS, Müller NE. Viruses and cancer: causal associations. Ann Epidemiol 1990;1:71-92.
23. Regamey N, Cathomas G, Schwager M, Wernli M, Harr T, Erb P. High human herpes virus 8 seroprevalence in the homosexual population in Switzerland. J Clin Microbial 1998;36:1784-1786.
24. Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C et al. Detection of Kaposi's sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995;346:799-802.
25. Goudsmit J, Renwick N, Dukers NH, Coutinho RA, Heisterkamp S, Bakker M et al. Human herpesvirus 8 infections in the Amsterdam Cohort Studies (1984-1997): analysis of seroconversions to ORF65 and ORF73. Proc Natl Acad Sci U S A 2000;97:4838-4843.
26. Gallo RC. Some aspects of the pathogenesis of HIV-1-associated Kaposi's sarcoma. J Natl Cancer Inst Monogr 1998;23:55-57.
27. Renwick N, Halaby T, Weverling GJ, Dukers NH, Simpson GR, Coutinho RA et al. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma. AIDS 1998;12:2481-2488.
28. Regamey N, Tamm M, Schwager M, Wernli M, Cathomas G, Erb P. Transmission of human herpes virus 8 (HHV8) infection from renal transplant donors to recipients. N Engl J Med 1998;339:1358-1363.
29. Frances C, Mouquet C, Marcelin AG, Barete S, Agher R, Charron D et al. Outcome of kidney transplant recipients with previous human herpesvirus-8 infection. Transplantation 2000;69:1776-1779.
30. WHO International Agency for Research on Cancer. Multistage carcinogenesis. In: World Cancer Report (Stewart BW, Kleihues P, eds). Lyon: IARC Press, 2003;pp84-88.
31. Nevins JR. Cell transformation by viruses. In: Fields Virology, 4th edn (Knipe DM, Howley PM, eds). Philadelphia: Lippincott Williams & Wilkins, 2001;pp245-283.
32. Flore O, Rafii S, Ely S, O'Leary JJ, Hyjek EM, Cesarman E. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature 1998;394:588-592.
33. Russo JJ, Bohenzky RA, Chien M-C, Chien J, Yan M, Maddalena D et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus 8. Proc Natl Acad Sci U S A 1996;93:14862-14867.
34. Arvanitakis L, Mesri EA, Nador RG, Said JW, Asch SA, Knowles DM et al. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. Blood 1996;88:2648-2654.
35. Sarid R, Flore O, Bohenzky RA, Chang Y, Moore PS. Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J Virol 1998;72:1005-1012.
36. Fakhari FD, Dittmer DP. Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR. J Virol 2002;76:6213-6223.
37. Dittmer DP. Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays. Cancer Res 2003:63:2010-2015.
38. Hayward G. Initiation of angiogenic Kaposi's sarcoma lesions. Cancer Cell 2003;3:1-3.
39. Dittmer D, Lagunoff M, Renne R, Staskus K, Haase A, Ganem D. A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus. J Virol 1998;72:8309-8315.
40. Sun R, Lin SF, Staskus K, Gradoville L. Grogan E, Haase A et al. Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression. J Virol 1999;73:2232-2242.
41. Rivas C, Thlick AE, Parravicini C, Moore PS, Chang Y. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J Virol 2001;75:429-438.
42. Ballestas ME, Chatis PA, Kaye KM. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 1999;284:641-644.
43. Friborg J, Jr, Kong W, Hottiger MO, Nabel GJ. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 1999;402:889-894.
44. Radkov SA, Kellam P, Boshoff C. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med 2000;6:1121-1127.
45. Reed JA, Nador RG, Spaulding D, Tani Y, Cesarman E, Knowles DM. Demonstration of Kaposi's sarcoma-associated herpes virus cyclin D homolog in cutaneous Kaposi's sarcoma by colorimetric in situ hybridization using a catalyzed signal amplification system. Blood 1998;91:3825-3832.
46. Chang Y, Moore PS, Talbot SJ, Boshoff CH, Zarkowska T, Godden K et al. Cyclin encoded by KS herpesvirus. Nature 1996;382:410.
47. Swanton C, Mann DJ, Fleckenstein B, Neipel F, Peters G, Jones N. Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins. Nature 1997;390:184-187.
48. Sturzl M, Hohenadl C, Zietz C, Castanos-Velez E, Wunderlich A, Ascherl G et al. Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells. J Natl Cancer Inst 1999;91:1725-1733.
49. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptor. Nature 1997;386:517-521.
50. Liu L, Eby MT, Rathore N, Sinha SK. Kumar A, Chaudhary PM. The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex. J Biol Chem 2002;277:13745-13751.
51. Mosialos G. The role of Rel/NF-kappa B proteins in viral oncogenesis and the regulation of viral transcription. Semin Cancer Biol 1997;8:121-129.
52. Cathomas G, Stalder A, Heitz PU. Differential expression of viral RNA detected by in situ hybridization with signal amplification in lesions associated with human herpesvirus 8 infection. Mod Pathol 2000;16:262A.
53. Muralidhar S, Pumfery AM, Hassani M, Seadie R, Azumi N, Kishishita M et al. Identification of Kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus transforming gene. J Virol 1998;72:4980-4988.
54. Gao S-J, Boshoff C, Jayachandra S, Weiss RA, Chang Y, Moore PS. KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene 1997;15:1979-1985.
55. Lin R, Genin P, Mamane Y, Sgarbanti M, Battistini A, Harrington WJ, Jr et al. HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coativators. Oncogene 2001;20:800-811.
56. Wang L, Grossman SR, Kieff E. Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMPI promoter. Proc Natl Acad Sci U S A 2000;97:430-435.
57. Arvanitakis L, Geras RE, Varma A, Gershengorn MC, Cesarman E. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 1997;385:347-350.
58. Bais C, Santomasso B, Coso O, Arvanitakis L, Raaka EG, Gutkind JS et al. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 1998;391:86-89.
59. Yang TY, Chen SC, Leach MW, Manfra D, Homey B, Wiekowski M et al. Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J Exp Med 2000;191:445-454.
60. Montaner S, Sodhi A, Molinolo A, Bugge TH, Sawai ET, He Y et al. Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell 2003;3:23-36.
61. Cheng EH, Nicholas J, Bellows DS, Hayward GS, Guo HG, Reitz MS et al. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Natl Acad Sci U S A 1997;94:690-694.
62. Widmer I, Wernli M, Bachmann F, Gudat F, Cathomas G, Erb P. Differential expression of viral Bcl-2 encoded by Kaposi's sarcoma-associated herpesvirus and human Bcl-2 in primary effusion lymphoma cells and Kaposi's sarcoma lesions. J Virol 2002;76:2551-2556.
63. Huang Q, Petros AM, Virgin HW, Fesik SW, Olejniczak ET. Solution structure of a Bcl-2 homolog from Kaposi sarcoma virus. Proc Natl Acad Sci U S A 2002;99:3428-3433.
64. Staskus KA, Sun R, Miller G, Racz P, Jaslowski A, Metroka C et al. Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. J Virol 1999;73:4181-4187.
65. Li H, Wang H, Nicholas J. Detection of direct binding of human herpesvirus 8-encoded interleukin-6 (vIL-6) to both gp130 and IL-6 receptor (IL-6R) and identification of amino acid residues of vIL-6 important for IL-6R-dependent and -independent signaling. J Virol 2001;75:3325-3334.
66. Chatterjee M, Osborne J, Bestetti G, Chang Y, Moore PS. Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science 2002;298:1432-1435.
67. Boshoff C, Endo Y, Collins PD, Takeuchi Y, Reeves JD, Schweickart VL et al. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 1997:278:290-294.
68. Stine JT, Wood C, Hill M, Epp A, Raport CJ, Schweickart VL et al. KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells. Blood 2000;95:1151-1157.